Substitution and exchange. 12.1 The Company may at any time and from time to time, with the consent of the Noteholders by Extraordinary Resolution, be replaced and substituted by any member of the Company’s Group as principal debtor or principal debtors (on one or more occasion) (in such capacity, the “Substituted Debtor”) in respect of all or any of the Notes provided that:
Appears in 9 contracts
Samples: Bgs649 Asset Purchase Agreement (Mereo Biopharma Group PLC), Bct197 Asset Purchase Agreement (Mereo Biopharma Group PLC), Bps804 Asset Purchase Agreement (Mereo Biopharma Group PLC)
